Skip to content
OpenCapital
Get started

Alaunos Therapeutics TCRT Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$0.55Beat by $4.35
EPS estimate-$4.90

Next report

Aug 18, 2026 (In 2 weeks)

Versus estimates

Revenue

Q4 2025$3.0KIn lineQ1 2025$2.0KQ4 2024$4.0K

Diluted EPS

Q1 2026-$0.59Q4 2025-$0.40Beat by $3.29
Q3 2025-$0.55Beat by $4.35
Q2 2025-$0.63Beat by $4.70Q1 2025-$0.67Beat by $5.77Q4 2024-$0.46Beat by $4.04

Ask the moment Alaunos Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Alaunos Therapeutics report Q3 2025 earnings?
Alaunos Therapeutics (TCRT) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Alaunos Therapeutics's Q3 2025 revenue and EPS?
Alaunos Therapeutics reported eps of $-0.55 for Q3 2025.
Did Alaunos Therapeutics beat estimates in Q3 2025?
EPS beat the consensus estimate of $-4.90 by $4.35.
How did Alaunos Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 21.4% from $-0.70.
Where can I find Alaunos Therapeutics's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001193125-25-282988) directly on SEC EDGAR. The filing index links above go to sec.gov.